BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18435757)

  • 1. Alternative binding proteins: biological activity and therapeutic potential of cystine-knot miniproteins.
    Kolmar H
    FEBS J; 2008 Jun; 275(11):2684-90. PubMed ID: 18435757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins.
    Kolmar H
    Curr Opin Pharmacol; 2009 Oct; 9(5):608-14. PubMed ID: 19523876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered cystine-knot miniproteins for diagnostic applications.
    Kolmar H
    Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of cystine-stabilized miniproteins as stable proteinaceous binders.
    Chang HJ; Hsu HJ; Chang CF; Peng HP; Sun YK; Yu HM; Shih HC; Song CY; Lin YT; Chen CC; Wang CH; Yang AS
    Structure; 2009 Apr; 17(4):620-31. PubMed ID: 19368895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering knottins as novel binding agents.
    Moore SJ; Cochran JR
    Methods Enzymol; 2012; 503():223-51. PubMed ID: 22230571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered cystine knot miniproteins as potent inhibitors of human mast cell tryptase beta.
    Sommerhoff CP; Avrutina O; Schmoldt HU; Gabrijelcic-Geiger D; Diederichsen U; Kolmar H
    J Mol Biol; 2010 Jan; 395(1):167-75. PubMed ID: 19852971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds.
    Vita C; Vizzavona J; Drakopoulou E; Zinn-Justin S; Gilquin B; Ménez A
    Biopolymers; 1998; 47(1):93-100. PubMed ID: 9692330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cyclotide family of circular miniproteins: nature's combinatorial peptide template.
    Craik DJ; Cemazar M; Wang CK; Daly NL
    Biopolymers; 2006; 84(3):250-66. PubMed ID: 16440288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafting of thrombopoietin-mimetic peptides into cystine knot miniproteins yields high-affinity thrombopoietin antagonists and agonists.
    Krause S; Schmoldt HU; Wentzel A; Ballmaier M; Friedrich K; Kolmar H
    FEBS J; 2007 Jan; 274(1):86-95. PubMed ID: 17147697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical synthesis and biosynthesis of the cyclotide family of circular proteins.
    Gunasekera S; Daly NL; Anderson MA; Craik DJ
    IUBMB Life; 2006 Sep; 58(9):515-24. PubMed ID: 17002979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive cystine knot proteins.
    Daly NL; Craik DJ
    Curr Opin Chem Biol; 2011 Jun; 15(3):362-8. PubMed ID: 21362584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural and engineered cystine knot miniproteins for diagnostic and therapeutic applications.
    Kolmar H
    Curr Pharm Des; 2011 Dec; 17(38):4329-36. PubMed ID: 22204431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic Cystine-Knot Miniproteins - Valuable Scaffolds for Polypeptide Engineering.
    Avrutina O
    Adv Exp Med Biol; 2016; 917():121-44. PubMed ID: 27236555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold.
    Souriau C; Chiche L; Irving R; Hudson P
    Biochemistry; 2005 May; 44(19):7143-55. PubMed ID: 15882053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of miniproteins by the transfer of active sites onto small-size scaffolds.
    Stricher F; Martin L; Vita C
    Methods Mol Biol; 2006; 340():113-49. PubMed ID: 16957335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, sequencing, and structure-activity relationships of cyclotides.
    Ireland DC; Clark RJ; Daly NL; Craik DJ
    J Nat Prod; 2010 Sep; 73(9):1610-22. PubMed ID: 20718473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins.
    Craik DJ; Clark RJ; Daly NL
    Expert Opin Investig Drugs; 2007 May; 16(5):595-604. PubMed ID: 17461734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.